OPM provides our partners with high quality cell culture media products and end-to-end biologics CDMO services. We support accelerating the process of biopharmaceutical development from DNA to IND and through manufacturing in clinical trail phases I and II.

≈ m²

8000

GMP facility for media manufacturing

≈ m²

10000

end-to-end biologics CDMO services

1000⁺

clients covering biopharmaceutical companies and research institutions

≈

200⁺

biologics at clinical trial phases have used OPM cell culture media and/or CDMO services